Cardiovascular Disease Update: Atrial Fibrillation

Area of Science:

• Cardiology
• Internal Medicine
• Family Medicine

Background:

• Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, with prevalence increasing significantly in older adults.
• AF frequently coexists with common family medicine conditions like hypertension and diabetes, necessitating integrated management strategies.

Purpose of the Study:

• To review current management strategies for atrial fibrillation, including rate and rhythm control, and anticoagulation.
• To highlight the importance of stroke risk stratification and appropriate therapeutic choices for patients with AF.

Main Methods:

• Review of current literature and clinical guidelines regarding atrial fibrillation management.
• Discussion of pharmacologic and non-pharmacologic treatment options for rate and rhythm control.
• Emphasis on stroke risk assessment using the CHA2DS2-VASc score and anticoagulation recommendations.

Main Results:

• Rate and rhythm control strategies demonstrate comparable mortality rates, though rhythm control may lead to more hospitalizations.
• Beta blockers and nondihydropyridine calcium channel blockers are key for rate control.
• Pharmacotherapy, electrical cardioversion, antiarrhythmic drugs, and catheter ablation are options for rhythm control.
• The CHA2DS2-VASc score is crucial for predicting stroke risk in AF patients.

Conclusions:

• Rhythm control can be a viable option for select symptomatic AF patients.
• Anticoagulation with warfarin or novel oral anticoagulants is recommended for nonvalvular AF patients with high stroke risk (CHA2DS2-VASc score ≥2) or history of stroke/TIA.
• Warfarin is the recommended anticoagulant for patients with valvular AF.